Dr Reddy's launches Redyx (Remdesivir) in India for COVID-19 treatment

Dr Reddy's launches Redyx (Remdesivir) in India for COVID-19 treatment The launch is part of a licensing agreement with Gilead Sciences Inc that grants Dr Reddy's the right to register, manufacture and sell Remdesivir, a potential treatment for COVID-19, in 127 countries including India. https://ift.tt/eA8V8J